Stevanato Group S.p.A (STVN) EBITDA Margin (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly EBITDA Margin came in at 12.93% in Q2 2026, down 184.0% year-over-year from 15.39% in Q2 2025, and down 8.68% quarter-over-quarter from 14.16% in Q1 2026.
Powered by 
Analysis
Stevanato Group S.p.A (STVN) EBITDA Margin (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported EBITDA Margin for 7 consecutive years, with 12.93% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 184.0% year-over-year to 12.93% in Q2 2026; TTM through Jun 2026 was 18.38%, a 64.0% increase from a year earlier, with the FY2025 full-year figure at 24.23%, up 233.0% from the prior year.
- EBITDA Margin was 12.93% for Q2 2026 at Stevanato Group S.p.A, down from 14.16% in the prior quarter.
- Over five years, EBITDA Margin peaked at 27.46% in Q4 2022 and troughed at 10.72% in Q1 2024.
- A 5-year average of 19.7% and a median of 17.63% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin surged 1302 bps in 2022 and plunged 1445 bps in 2024, its largest moves.
- Over 5 years, EBITDA Margin stood at 27.46% in 2022, then decreased by 4 bps to 26.23% in 2023, then fell by 0 bps to 26.19% in 2024, then grew by 4 bps to 27.33% in 2025, then plunged by 53 bps to 12.93% in 2026.
- The last three EBITDA Margin figures came in at 12.93% (Q2 2026), 14.16% (Q1 2026), and 27.33% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 13.31% |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 5.14% |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 20.53% |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 7.33% |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 12.93% |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 10.89% |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | -5.97% |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | -71.46% |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.93% |
| Mar 31, 2026 | 14.16% |
| Dec 31, 2025 | 27.33% |
| Sep 30, 2025 | 17.39% |
| Jun 30, 2025 | 14.77% |
| Mar 31, 2025 | 13.50% |
| Dec 31, 2024 | 26.19% |
| Sep 30, 2024 | 14.76% |
| Jun 30, 2024 | 10.77% |
| Mar 31, 2024 | 10.72% |
| Dec 31, 2023 | 26.23% |
| Sep 30, 2023 | 26.42% |
| Jun 30, 2023 | 25.22% |
| Mar 31, 2023 | 17.08% |
| Dec 31, 2022 | 27.46% |
| Sep 30, 2022 | 26.18% |
| Jun 30, 2022 | 25.53% |
| Mar 31, 2022 | 17.88% |
| Dec 31, 2021 | 25.19% |
| Sep 30, 2021 | 13.16% |